SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001768
Filing Date
2018-03-16
Accepted
2018-03-16 16:21:26
Documents
86
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234062z10-k.htm 10-K 2401486
2 EX-10.16 a2234062zex-10_16.htm EX-10.16 596786
3 EX-10.17 a2234062zex-10_17.htm EX-10.17 206914
4 EX-10.18 a2234062zex-10_18.htm EX-10.18 157834
5 EX-21.1 a2234062zex-21_1.htm EX-21.1 6593
6 EX-23.1 a2234062zex-23_1.htm EX-23.1 5207
7 EX-23.2 a2234062zex-23_2.htm EX-23.2 5422
8 EX-31.1 a2234062zex-31_1.htm EX-31.1 13282
9 EX-31.2 a2234062zex-31_2.htm EX-31.2 13275
10 EX-32.1 a2234062zex-32_1.htm EX-32.1 7233
11 EX-32.2 a2234062zex-32_2.htm EX-32.2 7133
18 G315240.JPG g315240.jpg GRAPHIC 73268
19 G470008.JPG g470008.jpg GRAPHIC 77682
20 G679197.JPG g679197.jpg GRAPHIC 77623
21 G992090.JPG g992090.jpg GRAPHIC 70794
22 G11342KK01I001.JPG g11342kk01i001.jpg GRAPHIC 2893
  Complete submission text file 0001047469-18-001768.txt   11432213

Data Files

Seq Description Document Type Size
12 EX-101.INS nbrv-20171231.xml EX-101.INS 2503594
13 EX-101.SCH nbrv-20171231.xsd EX-101.SCH 56777
14 EX-101.CAL nbrv-20171231_cal.xml EX-101.CAL 86155
15 EX-101.DEF nbrv-20171231_def.xml EX-101.DEF 258715
16 EX-101.LAB nbrv-20171231_lab.xml EX-101.LAB 571592
17 EX-101.PRE nbrv-20171231_pre.xml EX-101.PRE 460675
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 18695860
SIC: 2834 Pharmaceutical Preparations